TY - JOUR
T1 - Discovery of attenuation effect of orexin 1 receptor to aversion of nalfurafine
T2 - Synthesis and evaluation of D-nor-nalfurafine derivatives and analyses of the three active conformations of nalfurafine
AU - Nagumo, Yasuyuki
AU - Katoh, Koki
AU - Iio, Keita
AU - Saitoh, Tsuyoshi
AU - Kutsumura, Noriki
AU - Yamamoto, Naoshi
AU - Ishikawa, Yukiko
AU - Irukayama-Tomobe, Yoko
AU - Ogawa, Yasuhiro
AU - Baba, Takeshi
AU - Tanimura, Ryuji
AU - Yanagisawa, Masashi
AU - Nagase, Hiroshi
N1 - Funding Information:
This work was supported by JSPS KAKENHI (20K05743 to T.S.; 16H05098 to H.N., Y.I-T., T.S.; 18K11014 to Y.I-T., T.S.; 19K07314 to Y.I-T.), MEXT Grant-in-Aid for Scientific Research on Innovative Areas (JP15H05942 “LivinginSpace” to H.N.; JP17H06049 “Willdynamics” to Y.I-T.), Japan Foundation for Applied Enzymology (16H007 to T.S.) and Toray Industries, Inc. IIIS is also supported by the World Premier International Research Center ( WPI ) Initiative, Japan. We thank Prof. Minoru Narita (Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences) for in vivo experimental supports.
Funding Information:
This work was supported by JSPS KAKENHI (20K05743 to T.S.; 16H05098 to H.N. Y.I-T. T.S.; 18K11014 to Y.I-T. T.S.; 19K07314 to Y.I-T.), MEXT Grant-in-Aid for Scientific Research on Innovative Areas (JP15H05942 ?LivinginSpace? to H.N.; JP17H06049 ?Willdynamics? to Y.I-T.), Japan Foundation for Applied Enzymology (16H007 to T.S.) and Toray Industries, Inc. IIIS is also supported by the World Premier International Research Center (WPI) Initiative, Japan. We thank Prof. Minoru Narita (Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences) for in vivo experimental supports.
Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/9/1
Y1 - 2020/9/1
N2 - The D-nor-nalfurafine derivatives, which were synthesized by contraction of the six-membered D-ring in nalfurafine (1), had no affinity for orexin 1 receptors (OX1Rs). The 17N-lone electron pair in 1 oriented toward the axial direction, while that of D-nor-derivatives was directed in the equatorial configuration. The axial lone electron pair can form a hydrogen bond with the 14-hydroxy group, which could push the 6-amide side chain toward the downward direction with respect to the C-ring. The resulting conformation would be an active conformation for binding with OX1R. The dual affinities of 1 for OX1R and κ opioid receptor (KOR) led us to elucidate the mechanism by which only 1 showed no aversion but U-50488H. Actually, 1 selectively induced severe aversion in OX1R knockout mice, but not in wild-type mice. These results well support that OX1R suppresses the aversion of 1. This is the elucidation of long period puzzle which 1 showed no aversion in KOR.
AB - The D-nor-nalfurafine derivatives, which were synthesized by contraction of the six-membered D-ring in nalfurafine (1), had no affinity for orexin 1 receptors (OX1Rs). The 17N-lone electron pair in 1 oriented toward the axial direction, while that of D-nor-derivatives was directed in the equatorial configuration. The axial lone electron pair can form a hydrogen bond with the 14-hydroxy group, which could push the 6-amide side chain toward the downward direction with respect to the C-ring. The resulting conformation would be an active conformation for binding with OX1R. The dual affinities of 1 for OX1R and κ opioid receptor (KOR) led us to elucidate the mechanism by which only 1 showed no aversion but U-50488H. Actually, 1 selectively induced severe aversion in OX1R knockout mice, but not in wild-type mice. These results well support that OX1R suppresses the aversion of 1. This is the elucidation of long period puzzle which 1 showed no aversion in KOR.
KW - Aversion
KW - Nalfurafine
KW - Nalfurafine derivatives with 5 membered D-ring
KW - Orexin 1 receptor
KW - Sedation
UR - http://www.scopus.com/inward/record.url?scp=85087211815&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087211815&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2020.127360
DO - 10.1016/j.bmcl.2020.127360
M3 - Article
C2 - 32738987
AN - SCOPUS:85087211815
SN - 0960-894X
VL - 30
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 17
M1 - 127360
ER -